Financial results - PHARMAMED CONSULTING & INVESTMENT S.R.L.

Financial Summary - Pharmamed Consulting & Investment S.r.l.
Unique identification code: 39514899
Registration number: J23/2870/2018
Nace: 7499
Sales - Ron
597.355
Net Profit - Ron
192.305
Employees
2
Open Account
Company Pharmamed Consulting & Investment S.r.l. with Fiscal Code 39514899 recorded a turnover of 2024 of 597.355, with a net profit of 192.305 and having an average number of employees of 2. The company operates in the field of Alte activităţi profesionale, stiinţifice şi tehnice n.c.a. having the NACE code 7499.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Pharmamed Consulting & Investment S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - 14.783 138.506 691.150 1.429.848 403.525 891.549 597.355
Total Income - EUR - - - 14.783 138.507 691.218 1.429.803 409.599 899.092 614.586
Total Expenses - EUR - - - 11.102 87.323 424.650 957.396 368.854 690.027 382.051
Gross Profit/Loss - EUR - - - 3.681 51.183 266.569 472.407 40.746 209.065 232.535
Net Profit/Loss - EUR - - - 3.238 48.144 259.960 409.894 33.193 182.069 192.305
Employees - - - 0 2 4 5 4 4 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -32.6%, from 891.549 euro in the year 2023, to 597.355 euro in 2024. The Net Profit increased by 11.253 euro, from 182.069 euro in 2023, to 192.305 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Pharmamed Consulting & Investment S.r.l.

Rating financiar

Financial Rating -
PHARMAMED CONSULTING & INVESTMENT...

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Pharmamed Consulting & Investment...

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Pharmamed Consulting & Investment...

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Pharmamed Consulting & Investment...

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Pharmamed Consulting & Investment S.r.l. - CUI 39514899

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - 0 12.004 57.971 64.097 46.627 48.006 26.921
Current Assets - - - 6.098 58.873 346.897 636.231 293.413 529.296 551.399
Inventories - - - 563 5.724 60.329 105.478 209.563 116.209 109.685
Receivables - - - 946 42.346 279.222 246.020 85.164 427.725 462.433
Cash - - - 4.589 10.802 7.346 284.733 -1.315 -14.638 -20.719
Shareholders Funds - - - 3.281 51.361 260.010 409.943 33.242 182.724 192.353
Social Capital - - - 43 42 41 40 41 40 40
Debts - - - 2.817 19.515 144.858 290.385 306.798 394.578 385.967
Income in Advance - - - 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7499 - 7499"
CAEN Financial Year 7490
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 551.399 euro in 2024 which includes Inventories of 109.685 euro, Receivables of 462.433 euro and cash availability of -20.719 euro.
The company's Equity was valued at 192.353 euro, while total Liabilities amounted to 385.967 euro. Equity increased by 10.650 euro, from 182.724 euro in 2023, to 192.353 in 2024.

Risk Reports Prices

Reviews - Pharmamed Consulting & Investment S.r.l.

Comments - Pharmamed Consulting & Investment S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.